Dysregulated immunity and immunotherapy after sepsis

DB Darden, LS Kelly, BP Fenner, LL Moldawer… - Journal of clinical …, 2021 - mdpi.com
Implementation of protocolized surveillance, diagnosis, and management of septic patients,
and of surgical sepsis patients in particular, is shown to result in significantly increased …

The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later

PA Efron, SC Brakenridge, AM Mohr… - Journal of Trauma …, 2023 - journals.lww.com
Sepsis and trauma were the primary inciting events. With tremendous the advances in care
over the ensuing four decades, the epidemiology of MOF evolved from a fulminant …

[图书][B] Clinical anesthesia

PG Barash - 2009 - books.google.com
The premier single-volume reference in the field of anesthesia, Clinical Anesthesia is now in
its Sixth Edition, with thoroughly updated coverage, a new full-color design, and a revamped …

N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner

H Shen, K Xie, M Li, Q Yang, X Wang - Cell death discovery, 2022 - nature.com
Recent studies have identified that N6-methyladenosine (m6A) extensively participates in
the myocardial injury pathophysiological process. However, the role of m6A on sepsis …

Profiling the dysregulated immune response in sepsis: Overcoming challenges to achieve the goal of precision medicine

S Cajander, M Kox, BP Scicluna… - The Lancet …, 2023 - thelancet.com
Sepsis is characterised by a dysregulated host immune response to infection. Despite
recognition of its significance, immune status monitoring is not implemented in clinical …

Biomarker evidence of the persistent inflammation, immunosuppression and catabolism syndrome (PICS) in chronic critical illness (CCI) after surgical sepsis

DB Darden, SC Brakenridge, PA Efron, GL Ghita… - Annals of …, 2021 - journals.lww.com
Objective: To analyze serial biomarkers of the persistent inflammation, immunosuppression,
and catabolism syndrome (PICS) to gain insight into the pathobiology of chronic critical …

A novel single cell RNA-seq analysis of non-myeloid circulating cells in late sepsis

DB Darden, X Dong, MA Brusko, L Kelly… - Frontiers in …, 2021 - frontiersin.org
Background With the successful implementation of the Surviving Sepsis Campaign
guidelines, post-sepsis in-hospital mortality to sepsis continues to decrease. Those who …

[HTML][HTML] Utility of monocyte HLA-DR and rationale for therapeutic GM-CSF in sepsis immunoparalysis

I Joshi, WP Carney, EP Rock - Frontiers in immunology, 2023 - frontiersin.org
Sepsis, a heterogeneous clinical syndrome, features a systemic inflammatory response to
tissue injury or infection, followed by a state of reduced immune responsiveness …

[HTML][HTML] Adverse outcomes and an immunosuppressed endotype in septic patients with reduced IFN-γ ELISpot

EL Barrios, MB Mazer, PW McGonagill, CB Bergmann… - JCI insight, 2024 - ncbi.nlm.nih.gov
BACKGROUND Sepsis remains a major clinical challenge for which successful treatment
requires greater precision in identifying patients at increased risk of adverse outcomes …

Multi-Omics Endotypes in ICU Sepsis-Induced Immunosuppression

A Garduno, R Cusack, M Leone, S Einav… - Microorganisms, 2023 - mdpi.com
It is evident that the admission of some patients with sepsis and septic shock to hospitals is
occurring late in their illness, which has contributed to the increase in poor outcomes and …